Cauda equina syndrome is a rare nerve injury that, left untreated, can lead to permanent paralysis and incontinence. A timely diagnosis of cauda equina syndrome is crucial to avoid irreversible damage. In cases of misdiagnosis or delayed diagnosis, patients may have a basis for a malpractice action. For attorneys pursuing cauda equina syndrome cases, here’s what you need to know.
Community-acquired pneumonia (CAP) prognosis hinges on treatment timing and demographic risk factors. These criteria, plus many others, impact the appropriate course of action for CAP treatment—and could make the difference in whether a malpractice case exists. For attorneys pursuing community-acquired pneumonia treatment-related litigation, this is what you need to know.
The brachial plexus is a network of nerves located in the shoulder that originates from the neck. Recent research shows that certain shoulder replacement surgeries may cause brachial plexus injuries, resulting in numbness or paralysis. For attorneys pursuing brachial plexus injury matters, here’s what you need to know.
After Medtronic, a medical device company, received complaints concerning products from its HeartWare Ventricular Assist Device (HVAD) System, the FDA issued two separate recalls on the HVAD products. Given the product’s vital medical usage, complications or malfunctions can have high stakes implications for patients. For attorneys pursuing Medtronic HeartWare litigation, this is what you need to know.
The Paragard IUD, on the market since the 1980s, is an intrauterine device offering long-term contraception. The device, however, has become the focus of an increasing number of lawsuits by consumers alleging that the IUD can lead to serious injuries. For attorneys pursuing Paragard-related litigation, here’s what you need to know.
Elmiron, a drug used to treat bladder pain, has been linked to a severe degenerative eye disease, maculopathy. Now, long-term users are seeking damages via class action lawsuits and claiming drugmakers failed to give appropriate warning of the adverse side effects.
Proton pump inhibitors (PPIs), a category of heartburn medication, is the focus of a massive class action lawsuit alleging the drug led to kidney damage. For upcoming PPIs litigation, this is what you need to know.
In July 2019, the FDA issued a recall of a textured breast implant from maker, Allergan, after researchers found links to a rare cancer. Of the thousands of women impacted, many are turning to class actions. As you prepare Allergan-related cases, this litigation guide is a must-read.
After the FDA recalled heartburn medication, Zantac, for links to cancer, millions of former users were left uncertain about their health. Now, drugmakers are the targets for pending class action lawsuits with potential for huge settlements. For your upcoming Zantac litigation, this is what you need to know.
As airlines canceled thousands of flights during the pandemic, many travelers have been unable to secure refunds. Now, they’re turning to class actions against the major air carriers and seeking massive damages.